miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA (miRNA) deregulation is implicated in various cancers, including colorectal cancer (CRC).
• Investigating specific miRNA expression patterns, like miR-142-3p, is crucial for understanding CRC pathogenesis.

Purpose of the Study:

• To investigate the expression of miR-142-3p in primary colorectal cancer (CRC) tissues.
• To elucidate the functional role and molecular targets of miR-142-3p in CRC progression.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to assess miR-142-3p expression in 116 CRC tissues and adjacent non-tumor tissues.
• In vitro assays (cell viability, colony formation) and in vivo xenograft mouse models to evaluate the functional impact of miR-142-3p modulation.
• Dual-luciferase reporter assays to identify and validate potential molecular targets of miR-142-3p.

Main Results:

• miR-142-3p was significantly downregulated in 78.4% of primary CRC tissues compared to non-tumor controls.
• Upregulation of miR-142-3p using mimics suppressed CRC cell viability, colony formation, and in vivo tumor growth by inducing cell cycle arrest.
• Inhibition of miR-142-3p enhanced CRC cell proliferation and tumor growth.
• CDK4 was identified as a direct target of miR-142-3p, with its protein levels inversely correlated with miR-142-3p expression.

Conclusions:

• miR-142-3p functions as a tumor suppressor in colorectal cancer.
• Restoring miR-142-3p expression holds potential as a therapeutic strategy for CRC.
• Targeting miR-142-3p and its downstream effectors like CDK4 may offer novel avenues for CRC treatment.